The effect of bone morphogenic protein-2 (BMP-2)-immobilizing heparinized-chitosan scaffolds for enhanced osteoblast activity

Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 3, 2013, Pages 122-130

  Yun, Young Pil ^a   Kim, Sung Eun ^a   Kang, Eun Young ^a   Kim, Hak Jun ^a   Park, Kyeongsoon ^b   Song, Hae Ryong ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Bone morphogenic protein 2(BMP 2); Chitosan scaffolds; Enhancement of osteoblast functions; Heparin

Indexed keywords

BIOMATERIALS; BONE; CALCIUM; CELL PROLIFERATION; CELLS; CHITOSAN; DEPOSITION; PHOSPHATASES;

ALKALINE PHOSPHATASE ACTIVITY; BONE MORPHOGENIC PROTEIN; CHITOSAN SCAFFOLD; DENTAL TISSUE ENGINEERING; HEPARIN; MORPHOGENIC; OSTEOBLAST FUNCTION; SCAFFOLDING MATERIALS;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CHITOSAN; HEPARIN; IMMOBILIZED ENZYME; OSTEOCALCIN; OSTEOPONTIN; TISSUE SCAFFOLD;

ARTICLE; BONE TRANSPLANTATION; CELL ACTIVITY; CELL PROLIFERATION ASSAY; CYTOTOXICITY TEST; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; OSTEOBLAST;

EID: 84896700451     PISSN: 17382696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13770-013-0386-4     Document Type: Article

References (47)

1. A Khademhosseini, R Langer, J Borenstein, et al., Microscale technologies for tissue engineering and biology, Proc Natl Acad Sci USA, 103, 2480 (2006).
2. QP Pham, U Sharma, AG Mikos, Electrospun poly(epsiloncaprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration, Biomacromolecules, 7, 2796 (2006).
3. E Khor, LY Lim, Implantable applications of chitin and chitosan, Biomaterials, 24, 2339 (2003).
4. CKS Pillai, W Paul, CP Sharma, Chitin and chitosan polymers: chemistry, solubility and fiber formation, Progress Polym Sci, 34, 641 (2009).
5. AC Larkin, RM Davis, P Rajagopalan, Biocompatible, detachable, and free-standing polyelectrolyte multilayer films, Biomacromolecules, 11, 2788 (2010).
6. BG Amsden, A Sukarto, DK Knight, et al., Methacrylated glycol chitosan as a photopolymerizable biomaterial, Biomacromolecules, 8, 3758 (2007).
7. VK Mourya, NN Inamdar, Chitosan-modifications and applications: opportunities galore, React Funct Polym, 68, 1013 (2008).
8. D Depan, AK Pratheep, RP Singh, Cell proliferation and controlled drug release studies of nanohybrids based on chitosang- lactic acid and montmorillonite, Acta Biomater, 5, 93 (2009).
9. YY Liang, LM Zhang, Bioconjugation of papain on superparamagnetic nanoparticles decorated with carboxymethylated chitosan, Biomacromolecules, 8, 1480 (2007).
10. N Bordenave, S Grelier, V Coma, Hydrophobization and antimicrobial activity of chitosan and paper-based packaging material, Biomacromolecules, 11, 88 (2010).
11. Y Sheng, C Liu, Y Yuan, et al., Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan, Biomaterials, 30, 2340 (2009).
12. GK Tan, DL Dinnes, LN Butler, et al., Interactions between meniscal cells and a self assembled biomimetic surface composed of hyaluronic acid, chitosan and meniscal extracellular matrix molecules, Biomaterials, 31, 6104 (2010).
13. R Sasisekharan, S Ernst, G Venkataraman, On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans, Angiogenesis, 1, 45 (1997).
14. MJ Wissink, R Beernink, NM Scharenborg, et al., Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and procoagulant factors, J Control Release, 67, 141 (2000).
15. MJ Wissink, R Beernink, AA Poot, et al., Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices, J Control Release, 64,103 (2000).
16. GC Steffens, C Yao, P Prevel, et al., Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor, Tissue Eng, 10, 1502 (2004).
17. ST Nillesen, PJ Geutjes, R Wismans, et al., Increased angiogenesis and blood vessel maturation in acellular collageneheparin scaffolds containing both FGF2 and VEGF, Biomaterials, 28, 1123 (2007).
18. A Perets, Y Baruch, F Weisbuch, et al., Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres, J Biomed Mater Res A, 65, 489 (2003).
19. T Ishibe, T Goto, T Kodama, et al., Bone formation on apatitecoated titanium with incorporated BMP-2/heparin in vivo, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, 867 (2009).
20. SE Kim, SH Song, YP Yun, et al., The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function, Biomaterials, 32, 366 (2011).
21. HJ Moon, YP Yun, CW Han, et al., Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function, Biochem Biophys Res Commun, 413, 194 (2011).
22. DW Lee, YP Yun, K Park, et al., Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinizedtitanium implant with enhanced antibacterial activity and osteointegration, Bone, 50, 974 (2012).
23. ISO document 10993. Biological compatibility of medical devices*Part 5. Tests for cytotoxicity: in vitro methods, December 1992.
24. Z Shi, KG Neoh, ET Kang, et al., Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration, Biomacromolecules, 10, 1603 (2009).
25. RH Christenson, Biochemical markers of bone metabolism: an overview, Clin Biochem, 30, 573 (1997).
26. NK Lee, H Sowa, E Hinoi, et al., Endocrine regulation of energy metabolism by the skeleton, Cell, 130, 456 (2007).
27. K Whang, KE Healy, DR Elenz, et al., Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture, Tissue Eng, 5, 35 (1999).
28. MC Wake, Jr CW Patrick, AG Mikos, Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates, Cell Transplant, 3, 339 (1994).
29. N Sykaras, LA Opperman, Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician?, J Oral Sci, 45, 57 (2003).
30. BS Vladimirov, SA Dimitrov, Growth factors-importance and possibilities for enhancement of the healing process in bone fractures, Folia Med (Plovdiv), 46, 11 (2004).
31. JM Wozney, V Rosen, AJ Celeste, et al., Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528 (1988).
32. MR Urist, Bone: formation by autoinduction, Science, 150, 893 (1965).
33. S Hirota, K Takaoka, J Hashimoto, et al., Expression of mRNA of murine bone-related proteins in ectopic bone induced by murine bone morphogenetic protein-4, Cell Tissue Res, 277, 27 (1994).
34. J Becerra, JA Andrades, JA Santamaria, et al., Bone regeneration, cell therapy and tissue engineering, Med Clin (Barc), 116, 23 (2001).
35. BE Bax, JM Wozney, DE Ashhurst, Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia, Calcif Tissue Int, 65, 83 (1999).
36. GN King, N King, AT Cruchley, et al., Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects, J Dent Res, 76, 1460 (1997).
37. RS Sellers, D Peluso, EA Morris, The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage, J Bone Jt Surg Am, 79, 1452 (1997).
38. G Zellin, A Linde, Importance of delivery systems for growthstimulatory factors in combination with osteopromotive membranes. an experimental study using rhBMP-2 in rat mandibular defects, J Biomed Mater Res, 35, 181 (1997).
39. J Kim, Y Park, G Tae, et al., Characterization of low-molecularweight hyaluronic acid-based hydrogel and differential stem cell responses in the hydrogel microenvironments, J Biomed Mater Res A, 88, 967 (2009).
40. J Kim, IS Kim, TH Cho, et al., Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells, Biomaterials, 28, 1830 (2007).
41. H Lin, Y Zhao, W Sun, et al., The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2, Biomaterials, 29, 1189 (2008).
42. S Yang, KF Leong, Z Du, et al., The design of scaffolds for use in tissue engineering. Part I. traditional factors, Tissue Eng, 7, 679 (2001).
43. K Turksen, U Bhargava, HK Moe, et al., Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo, J Histochem Cytochem, 40, 1339 (1992).
44. JJ van den Beucken, XF Walboomers, OC Boerman, et al., Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2, J Control Release, 113, 63 (2006).
45. YJ Park, KH Kim, JY Lee, et al., Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration, Biotechnol Appl Biochem, 43, 17 (2006).
46. ST Choi, JH Kim, EJ Kang, et al., Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis, Rheumatology, 47, 1775 (2008).
47. F Deschaseaux, L Sensebe, D Heymann, Mechanisms of bone repair and regeneration, Trends Mol Med, 15, 417 (2009).